EVT 302 + Placebo + EVT 302 plus open label Nicotine replacement + Placebo plus open label Nicotine Replacement
Phase 2Completed 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Aug 1, 2008 → May 1, 2009
NCT ID
NCT00738595About EVT 302 + Placebo + EVT 302 plus open label Nicotine replacement + Placebo plus open label Nicotine Replacement
EVT 302 + Placebo + EVT 302 plus open label Nicotine replacement + Placebo plus open label Nicotine Replacement is a phase 2 stage product being developed by Evotec for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00738595. Target conditions include Smoking Cessation.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00738595 | Phase 2 | Completed |
Competing Products
20 competing products in Smoking Cessation